IBM’s AuthMind Acquisition Extends Its Push Into Cybersecurity
IBM’s AuthMind acquisition reinforces its cybersecurity and hybrid-cloud strategy, while leaving investors to assess the deal’s execution potential.
Hancock Whitney-Trustmark Deal Signals Fresh Wave of Regional Bank Consolidation
Hancock Whitney’s approximately $3.2 billion all-stock acquisition of Trustmark highlights renewed c…
Investcorp Credit Management BDC Surges More Than 50% on BCP Investment Merger Deal
Investcorp Credit Management BDC shares jumped more than 50% after news of a merger deal with BCP In…
Costco Announces Special Dividend as Shareholders Watch Holiday Payout
Costco’s special dividend highlights its capital-return strategy, while shareholders focus on the re…
Installed Building Products’ $698 Million Old Dominion Deal Puts Sector Consolidation in Focus
Installed Building Products’ $698 million acquisition of Old Dominion Group highlights consolidation…
Half-Point Fed Hike Risk Raises Stakes for U.S. Stocks, Bonds and Housing
A possible half-point Fed hike is jolting expectations across stocks, bonds, mortgages, corporate cr…
JetBlue CEO Bets on Premium Strategy Despite Creditor Concerns
JetBlue is betting that premium offerings and new first-class seats can support its turnaround as cr…
Sabre Shares Jump on Report of Potential Travelport Combination
Sabre shares jumped after a report of a possible Travelport combination, putting GDS competition and…
Hot Inflation Data Sends Mortgage Rates Higher as Wall Street Rate-Cut Hopes Fade
Hotter inflation and hawkish Fed commentary pushed mortgage rates sharply higher, pressuring Wall St…
Retail Sales Growth Slows to Nearly One-Year Low as Consumer Strain Builds
October retail-sales growth slowed to a nearly one-year low, raising concerns about consumer strain,…
Altius Minerals’ $122 Million TNR Gold Deal Signals Fresh Canadian Mining Consolidation
Altius Minerals’ agreement to acquire TNR Gold for $122 million highlights renewed consolidation acr…
Reuters Poll Points to Another Fed Rate Hike as Inflation Risks Persist
A Reuters economist poll points to one more Fed rate hike in December, complicating expectations for…
Chip Stocks Rally Despite Nvidia Scandal as Traders Test a Potential Market Bottom
Chip stocks rallied despite Nvidia-related headlines, testing whether markets can form a bottom whil…
Markets
- GFL Environmental Drops After Strategic Review Ends Without a Sale
- GFL Ends Strategic Review After Rejecting $52-a-Share Private Equity Offer
- LCI Board Rejects Revised Monomoy Buyout Bid, Keeping M&A Premium in Focus
- Goodyear’s CEO Exit Puts Turnaround Execution Under Interim Leadership
Economy
- US Payrolls Beat and Canadian Jobs Miss Push USD/CAD Higher
- Payrolls Crush Expectations as Traders Reprice Fed Rate-Cut Bets
- Gold Jumps 3% as Dollar Weakens After Democratic Midterm Gains
- US Factory Orders Rise 1.8%, Beating Expectations in September
Analysis
- Airbnb Shares Rise 5.64% as Golden Cross Signals Renewed Technical Momentum
- Donchian Channel Breakout: 10-Year ETF Backtest
- MACD vs Moving Average Crossover: 9-Year SPY, QQQ Test
- ADX Trend Strength: What 10 Years of ETF Data Show
Earnings
- Boeing’s 5% Workforce Cut Signals Slower Commercial-Airplane Recovery
- ConocoPhillips Raises Dividend After Earnings Beat as Oil Prices Support Results
- Utz Brands Reports Third-Quarter Results as Snack Investors Track Consumer Pressures
- Marathon Petroleum’s Earnings Beat Puts Refining Consolidation in the Spotlight
Technology
- Meta Executive’s Move to Fireworks Highlights Intensifying AI Talent War
- Palo Alto Networks’ Reported $500 Million Clutch Talks Put AI Security M&A in Focus
- CrowdStrike’s $495 Million AI Security Bet Puts Autonomous Defense in Focus
- Oracle’s $20 Billion Stock-and-Bond Fundraising Shows the Cost of the AI Buildout
IPO
- Anthropic IPO Filing Ignites Tech Rally While Founder Control Tests Investors
- TriGemX Bio’s $600 Million SPAC Merger Creates a New Nasdaq Biotech Watchlist Name
- XTEND AI Robotics: Analyzing the Market Implications of Its NYSE Debut
- Werewolf Therapeutics and Ambros' Merger: A New Era in Biotech